tyloxapol has been researched along with Bile Duct Obstruction, Intrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexeenko, TV; Korolenko, TA; Savchenko, NG; Sorochinskaya, NV; Yuz'ko, JV | 1 |
| Alexeenko, TV; Filatova, TG; Goncharova, IA; Korolenko, TA; Savchenko, NG; Yuz'ko, YV | 1 |
2 other study(ies) available for tyloxapol and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Activity of lysosomal enzymes in the bile and serum of mice with intrahepatic cholestasis.
Topics: 1-Naphthylisothiocyanate; Alkaline Phosphatase; Animals; beta-Galactosidase; beta-N-Acetylhexosaminidases; Bile; Cholestasis, Intrahepatic; Cholesterol; gamma-Glutamyltransferase; Hexosaminidases; Lysosomes; Male; Mice; Mice, Inbred CBA; Polyethylene Glycols | 2008 |
Changes in the concentration of tissue inhibitor of type 1 metalloproteinases in blood serum and liver of mice with CCl4-induced hepatitis.
Topics: Animals; Bile; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Liver; Male; Mice; Mice, Inbred CBA; Polyethylene Glycols; Tissue Inhibitor of Metalloproteinase-1 | 2007 |